BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1469 related articles for article (PubMed ID: 29036890)

  • 1. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Highlight of Recent Advances in Aptamer Technology and Its Application.
    Sun H; Zu Y
    Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current approaches in SELEX: An update to aptamer selection technology.
    Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer Selection for Detecting Molecular Target Using Cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) Technology.
    Stewart KD; Tan W; Park JY
    Methods Mol Biol; 2019; 2054():223-241. PubMed ID: 31482459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications.
    Xiao X; Li H; Zhao L; Zhang Y; Liu Z
    Biomed Pharmacother; 2021 Nov; 143():112232. PubMed ID: 34649356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX.
    Lyu Y; Chen G; Shangguan D; Zhang L; Wan S; Wu Y; Zhang H; Duan L; Liu C; You M; Wang J; Tan W
    Theranostics; 2016; 6(9):1440-52. PubMed ID: 27375791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
    Sriramoju B; Kanwar R; Veedu RN; Kanwar JR
    Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers in targeted nanotherapy.
    Mathew A; Maekawa T; Sakthikumar D
    Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in cell-SELEX technology for aptamer selection.
    Kaur H
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2323-2329. PubMed ID: 30059712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamers in hematological malignancies and their potential therapeutic implications.
    Ouyang W; Yu Z; Zhao X; Lu S; Wang Z
    Crit Rev Oncol Hematol; 2016 Oct; 106():108-17. PubMed ID: 27637356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
    Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
    Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in selection and biomedical applications of aptamers.
    Xi Z; Huang R; Deng Y; He N
    J Biomed Nanotechnol; 2014 Oct; 10(10):3043-62. PubMed ID: 25992428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generating aptamers by cell-SELEX for applications in molecular medicine.
    Ye M; Hu J; Peng M; Liu J; Liu J; Liu H; Zhao X; Tan W
    Int J Mol Sci; 2012; 13(3):3341-3353. PubMed ID: 22489154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.
    Mallikaratchy P
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28146093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in aptamer screening technologies.
    Yan J; Xiong H; Cai S; Wen N; He Q; Liu Y; Peng D; Liu Z
    Talanta; 2019 Aug; 200():124-144. PubMed ID: 31036165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.